Utah Retirement Systems’s Myriad Genetics MYGN Stock Holding History

Utah Retirement Systems’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-13,306	Closed	-$471K	–	1033
2015 Q1	$471K	Buy	13,306 +500	+4%	+$17.9K	0.01%	908
2014 Q4	$436K	Hold	12,806	–	–	0.01%	926
2014 Q3	$494K	Sell	12,806 -100	-0.8%	-$3.73K	0.01%	888
2014 Q2	$502K	Sell	12,906 -500	-4%	-$18.6K	0.01%	899
2014 Q1	$458K	Hold	13,406	–	–	0.01%	896
2013 Q4	$281K	Sell	13,406 -700	-5%	-$17.7K	0.01%	965
2013 Q3	$331K	Sell	14,106 -100	-0.7%	-$2.84K	0.01%	940
2013 Q2	$382K	Buy	+14,206	New	+$412K	0.01%	906

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Utah Retirement Systems's MYGN Position: Q2 2015 in Review

Utah Retirement Systems sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 13,306 shares — an estimated $471K sold.

Utah Retirement Systems first reported a position in MYGN in Q2 2013 and held it in 8 quarters. The position peaked at $502K in Q2 2014. 234 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

Utah Retirement Systems reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
Utah Retirement Systems sold 13,306 Myriad Genetics shares in Q2 2015, an estimated $471K.
Utah Retirement Systems first reported a position in Myriad Genetics in Q2 2013 and held it in 8 quarters.
Utah Retirement Systems's Myriad Genetics position peaked at $502K in Q2 2014.
234 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on Utah Retirement Systems's 13F filing for Q2 2015, filed 11 Aug 2015.